More Information Product Details
Synonyms Lymphocyte Activation Gene-3; FDC Protein; CD223 |
Product Type Protein |
Properties
Source/Host CHO cells |
Sequence The sequence coding for the 4 extracellular Ig-like domains of mouse LAG-3 (D1-D4) is fused to the Fc portion of mouse IgG2a (hinge-CH2-CH3). |
Crossreactivity HumanMouse |
Specificity Binds to human and mouse MHC class II. |
Biological Activity Induces maturation of mouse dendritic cells in vitro. Induces CD4 and CD8 antigen-specific T cells responses when coinjected s.c. in mice, together with the antigen. |
MW ~180kDa (SPS-PAGE, nonreducing), ~80kDa (SPS-PAGE, reducing) |
Purity ≥95% (SDS-PAGE) |
Endotoxin Content |
Concentration 0.5 mg/ml |
Formulation Liquid. In PBS. |
Other Product Data Application: Flow Cytometry: Detection of MHC class II molecules in combination with fluorescently labeled antibodies to IgG2a. Uni-Prot link Q61790: LAG-3 (mouse) |
Shipping and Handling
Shipping DRY ICE |
Short Term Storage -20°C |
Long Term Storage -20°C |
Handling Advice After opening, prepare aliquots and store at -20°C.Avoid freeze/thaw cycles.PBS containing at least 0.1% BSA should be used for further dilutions. |
Use/Stability Stable for at least 6 months after receipt when stored at -20°C. |
Documents
MSDS Download PDF |
Product Specification Sheet
Datasheet Download PDF |
Lymphocyte activation gene 3 (LAG-3; CD223) plays an important role in negatively regulating T cell proliferation, function and homeostasis. It is required for maximal natural and induced regulatory T cell (Treg) function. LAG-3 is closely related to the T cell co-receptor CD4 and binds to MHC class II molecules but with a significantly higher affinity than CD4.
Product References
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice: P. Cappello, et al.; Cancer Res. 63, 2518 (2003)